MobiHealth News January 16, 2026
Silicon Valley Bank head of healthcare and life sciences says the bank’s strategy has remained the same since its collapse in 2023.
SAN FRANCISCO – Nearly two years after Silicon Valley Bank’s collapse sent shockwaves through venture-backed healthcare and MedTech companies, the bank’s head of healthcare and life sciences says its core strategy remains largely unchanged.
Megan Scheffel, head of healthcare and life sciences at Silicon Valley Bank, sat down with MobiHealthNews outside the JPM Healthcare Conference here on Wednesday to discuss the current state of investing, capital trends and why she says the bank’s core strategy has remained consistent following one of the largest bank failures in U.S. history.
MobiHealthNews: Tell me a bit about what you do at...
Today's Sponsors
Today's Sponsor